— Know what they know.
Not Investment Advice
Also trades as: BIAFW (NASDAQ) · $vol 0M

BIAF NASDAQ

bioAffinity Technologies, Inc.
1W: -23.6% 1M: -37.9% 3M: -50.0% YTD: -66.9% 1Y: -86.1% 3Y: -98.8%
$6.05
-0.09 (-1.46%)
 
Weekly Expected Move ±46.2%
$0 $3 $6 $9 $12
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 28 · $2.5M mcap · 294799 float · 704.12% daily turnover · Short 40% of daily vol

Balance Sheet Trends

Total Assets
$11M +68.3% ▲
5Y CAGR: +137.3%
Total Liabilities
$4M -5.8% ▼
5Y CAGR: -24.7%
Shareholders Equity
$7M +179.7% ▲
Cash & Investments
$6M +483.5% ▲
5Y CAGR: +138.8%
Total Debt
$1M -22.7% ▼
5Y CAGR: -35.0%
Net Debt
-$5M -1435.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1M$11M$3M$1M$6M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$1M$11M$3M$1M$6M
Net Receivables$2K$10K$812K$1M$542K
Inventory$0$6K$18K$28K$54K
Other Current Assets$59K$192K$125K$147K$520K
Total Current Assets$1M$12M$4M$3M$8M
Property, Plant & Equip.$5K$214K$2M$2M$1M
Goodwill & Intangibles$0$0$2M$2M$2M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$10K$6K$16K$20K$13K
Total Non-Current Assets$15K$220K$4M$4M$3M
Total Assets$1M$12M$8M$7M$11M
— Liabilities —
Accounts Payable$230K$345K$605K$987K$762K
Short-Term Debt$11M$252K$0$172K$384K
Deferred Revenue$0$0$33K$24K$42K
Other Current Liabilities$0$341K$857K$0$2M
Total Current Liabilities$13M$1M$2M$3M$3M
Long-Term Debt$160K$0$0$20K$777K
Other Non-Current Liab.$4M$0$0$0$0
Total Non-Current Liabilities$4M$0$1M$807K$777K
Total Liabilities$17M$1M$3M$4M$4M
— Equity —
Common Stock$19K$59K$66K$107K$31K
Retained Earnings-$29M-$37M-$45M-$54M-$69M
Accumulated OCI-$4M$0$0$0$0
Total Stockholders Equity-$16M$11M$5M$3M$7M
Total Liabilities & Equity$1M$12M$8M$7M$11M
— Key Metrics —
Total Debt$11M$252K$2M$2M$1M
Net Debt$10M-$11M-$1M$396K-$5M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms